In vivo fluorescence imaging of exogenous enzyme activity in the gastrointestinal tract

Abstract

Exogenous enzymes are administered orally to treat several diseases, such as pancreatic insufficiency and lactose intolerance. Due to the proteinaceous nature of enzymes, they are subject to inactivation and/or digestion in the gastrointestinal (GI) tract. Here we describe a convenient fluorescence-based assay to monitor the activity of therapeutic enzymes in real time in vivo in the GI tract. To establish the proof of principle, the assay was applied to proline-specific endopeptidases (PEPs), a group of enzymes recently proposed as adjuvant therapy for celiac disease (a highly prevalent immunogenetic enteropathy). A short PEP-specific peptide sequence which is part of larger immunotoxic sequences of gluten was labeled with a fluorescent dye and a corresponding quencher. Upon enzymatic cleavage, the fluorescence emission was dequenched and detected with an in vivo imaging system. PEPs originating from Flavobacterium meningosepticum (FM) and Myxococcus xanthus (MX) were evaluated after oral administration in rats. While MX PEP could not cleave the peptide in the stomach, FM PEP showed significant gastric activity reaching 40–60% of the maximal in vivo signal intensity. However, both enzymes produced comparable fluorescence signals in the small intestine. Coadministration of an antacid drug significantly enhanced MX PEP’s gastric activity due to increased pH and/or inhibition of stomach proteases. With this simple procedure, differences in the in vivo performance of PEPs, which could not be identified under in vitro conditions, were detected. This imaging assay could be used to study other oral enzymes in vivo and therefore be instrumental in improving their therapeutic efficiency.

A Broader View: Microbial Enzymes and Their Relevance in Industries, Medicine, and Beyond

“…This can lead to mental retardation if the disease is untreated in early childhood [143]. Another example of enzyme deficiency is germline mutations in genes coding for DNA repair enzymes which cause hereditary cancer syndromes such as xeroderma pigmentosum [144]. Defects in these enzymes cause cancer since the body is less able to repair mutations in the genome.…”

A high-throughput assay for quantifying appetite and digestive dynamics

“…Technically, even more demanding than measuring food intake is the quantification of nutrient digestion, as there is no direct optical access to the gastrointestinal tract in most species. More specialized technologies, such as bioluminescence, MRI, or computed tomography, have been valuable to generate insights into in vivo dynamics of digestive function (10,18,19,31). However, all of these methods require immobilization of the experimental subject to reduce motion artifacts, thereby making concurrent behavioral observations impossible.…”

Semi-permeable coatings fabricated from comb-polymers efficiently protect proteins in vivo

“…Leroux and co-workers recently demonstrated that the functionality of different polymers grafted to proline-specific endopeptidases could be manipulated to stabilize and alter the dwell time of orally administered enzymes at different locations in the gastrointestinal tract 10 . Such studies are crucial because trends and observations made in vitro often do not correlate with in vivo observations 11 . This is in part due to the complex and potentially unpredictable nature of the interactions between the conjugate and components of the body.…”